Yolk Sac Tumor of the Ovary: A Retrospective Multicenter Study of 33 Japanese Women by Tohoku Gynecologic Cancer Unit (TGCU)Takanobu Kojimahara, Hirohisa Kurachi, Kenji Nakahara et al.|The Tohoku Journal of Experimental Medicine|2013Cited by 31
A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit StudyHideki Mizunuma, Yoshihito Yokoyama, Toru Sugiyama et al.|Oncology Reports|2008Cited by 27
Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)Tadahiro Shoji, Toru Sugiyama, Eriko Takatori et al.|International Journal of Gynecological Cancer|2010Cited by 18
Paclitaxel–carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit StudyTadao Takano, Junzo Kigawa, Takeo Otsuki et al.|International Journal of Clinical Oncology|2014Cited by 12
Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancerYoshihito Yokoyama, Hideki Mizunuma, Masayuki Futagami et al.|Molecular and Clinical Oncology|2013Cited by 9